Does ADALIMUMAB Cause Bladder cancer recurrent? 19 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Bladder cancer recurrent have been filed in association with ADALIMUMAB (YUSIMRY). This represents 0.0% of all adverse event reports for ADALIMUMAB.
19
Reports of Bladder cancer recurrent with ADALIMUMAB
0.0%
of all ADALIMUMAB reports
2
Deaths
11
Hospitalizations
How Dangerous Is Bladder cancer recurrent From ADALIMUMAB?
Of the 19 reports, 2 (10.5%) resulted in death, 11 (57.9%) required hospitalization, and 2 (10.5%) were considered life-threatening.
Is Bladder cancer recurrent Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB. However, 19 reports have been filed with the FAERS database.
What Other Side Effects Does ADALIMUMAB Cause?
Drug ineffective (71,926)
Pain (37,514)
Arthralgia (35,592)
Rheumatoid arthritis (29,817)
Fatigue (29,420)
Injection site pain (28,679)
Headache (19,891)
Nausea (19,299)
Rash (18,690)
Pain in extremity (18,319)
What Other Drugs Cause Bladder cancer recurrent?
BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN (231)
PIOGLITAZONE (130)
RANITIDINE (66)
BACILLUS CALMETTE-GUERIN ANTIGEN, UNSPECIFIED SUBSTRAIN (28)
MITOMYCIN (20)
PEMBROLIZUMAB (20)
GEMCITABINE\GEMCITABINE (19)
METHOTREXATE (16)
GEMCITABINE (15)
INTERFERON ALFA-2B (14)
Which ADALIMUMAB Alternatives Have Lower Bladder cancer recurrent Risk?
ADALIMUMAB vs ADALIMUMAB-AACF
ADALIMUMAB vs ADALIMUMAB-AATY
ADALIMUMAB vs ADALIMUMAB-ADAZ
ADALIMUMAB vs ADALIMUMAB-ADBM
ADALIMUMAB vs ADALIMUMAB-AFZB